{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:45:10Z","timestamp":1789674310974,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctoral\u00a0Fellowship\u00a0Program\u00a0of CPSF","award":["GZB20230037"],"award-info":[{"award-number":["GZB20230037"]}]},{"name":"National Social Science Fund of China","award":["21&ZD187"],"award-info":[{"award-number":["21&ZD187"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11275-w","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T08:40:05Z","timestamp":1751704805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunogenicity and safety of the domestic and imported live-attenuated varicella vaccine in healthy Chinese populations: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yemin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"11275_CR1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/molecules26041132","volume":"26","author":"G Andrei","year":"2021","unstructured":"Andrei G, Snoeck R. Advances and perspectives in the management of Varicella-Zoster virus infections. Molecules. 2021;26:1132.","journal-title":"Molecules"},{"key":"11275_CR2","doi-asserted-by":"publisher","first-page":"e0011622","DOI":"10.1128\/mmbr.00116-22","volume":"87","author":"AM Arvin","year":"2023","unstructured":"Arvin AM. Creating the dew drop on a Rose petal: the molecular pathogenesis of Varicella-Zoster virus skin lesions. Microbiol Mol Biol Rev. 2023;87:e0011622.","journal-title":"Microbiol Mol Biol Rev"},{"key":"11275_CR3","first-page":"265","volume":"89","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Varicella and herpes Zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89:265\u201387.","journal-title":"Wkly Epidemiol Rec"},{"key":"11275_CR4","doi-asserted-by":"publisher","first-page":"2266225","DOI":"10.1080\/21645515.2023.2266225","volume":"19","author":"I Williame","year":"2023","unstructured":"Williame I, George M, Shah HA, et al. Healthcare resource use and costs of varicella and its complications: A systematic literature review. Hum Vaccin Immunother. 2023;19:2266225.","journal-title":"Hum Vaccin Immunother"},{"key":"11275_CR5","first-page":"155","volume":"25","author":"H Sui","year":"2019","unstructured":"Sui H, Li J, Wang M, et al. Varicella epidemiology in china, 2005\u20132015. Chin J Vaccin Immuniz. 2019;25:155\u20139.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR6","first-page":"403","volume":"26","author":"P Dong","year":"2020","unstructured":"Dong P, Wang M, Liu Y. Epidemiological characteristics of varicella in china, 2016\u20132019. Chin J Vaccin Immuniz. 2020;26:403\u20136.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR7","first-page":"274","volume":"29","author":"M Wang","year":"2023","unstructured":"Wang M, Zeng X, Zhang Y, et al. Epidemiological characteristics of varicella public health emergency events in china, 2007\u20132021. Chin J Vaccin Immuniz. 2023;29:274\u20139.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR8","doi-asserted-by":"crossref","unstructured":"Otani N, Shima M, Yamamoto T et al. Effect of routine varicella immunization on the epidemiology and immunogenicity of varicella and shingles. Viruses. 2022;14:588.","DOI":"10.3390\/v14030588"},{"key":"11275_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1542\/peds.2010-0962","volume":"127","author":"AS Lopez","year":"2011","unstructured":"Lopez AS, Zhang J, Brown C, et al. Varicella-related hospitalizations in the united states, 2000\u20132006: the 1-dose varicella vaccination era. Pediatrics. 2011;127:238\u201345.","journal-title":"Pediatrics"},{"key":"11275_CR10","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1093\/infdis\/jiac242","volume":"226","author":"M Marin","year":"2022","unstructured":"Marin M, Lopez AS, Melgar M, et al. Decline in severe varicella disease during the united States varicella vaccination program: hospitalizations and deaths, 1990\u20132019. J Infect Dis. 2022;226:S407\u201315.","journal-title":"J Infect Dis"},{"key":"11275_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.vaccine.2023.10.031","volume":"42","author":"L Huang","year":"2024","unstructured":"Huang L, Chen Z, Song Y, et al. Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study. Vaccine. 2024;42:396\u2013401.","journal-title":"Vaccine"},{"key":"11275_CR12","first-page":"698","volume":"23","author":"A Liu","year":"2017","unstructured":"Liu A, Sun T. Meta-analysis of varicella vaccine coverage among Chinese children. Chin J Vaccin Immuniz. 2017;23:698\u2013704.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR13","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1016\/j.vaccine.2014.10.076","volume":"32","author":"R Gil-Prieto","year":"2014","unstructured":"Gil-Prieto R, Garcia-Garcia L, San-Martin M, et al. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain. Vaccine. 2014;32:7043\u20136.","journal-title":"Vaccine"},{"key":"11275_CR14","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4161\/hv.34426","volume":"10","author":"A Siedler","year":"2014","unstructured":"Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10:3594\u2013600.","journal-title":"Hum Vaccin Immunother"},{"key":"11275_CR15","first-page":"1650","volume":"42","author":"Y Hu","year":"2021","unstructured":"Hu Y, Luo X, Lv M, et al. A Meta-analysis on varicella-zoster virus antibody levels in healthy population in China. Chin J Epidemiol. 2021;42:1650\u201361.","journal-title":"Chin J Epidemiol"},{"key":"11275_CR16","doi-asserted-by":"publisher","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","volume":"137","author":"M Marin","year":"2016","unstructured":"Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: A Meta-analysis. Pediatrics. 2016;137:e20153741.","journal-title":"Pediatrics"},{"key":"11275_CR17","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"11275_CR18","first-page":"919","volume":"3","author":"Q Liu","year":"2014","unstructured":"Liu Q, Zhai W, Tan YQ, et al. Analysis on evaluation tool for literature quality in clinical study. Chin Acupunct Mox. 2014;3:919\u201322.","journal-title":"Chin Acupunct Mox"},{"key":"11275_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1\u201312.","journal-title":"Control Clin Trials"},{"key":"11275_CR20","unstructured":"Wells G, Shea B, O\u2019Connell D et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2016. Available from: http:\/\/www.ohri.ca\/programs\/clinicalepidemiology\/oxford.asp"},{"key":"11275_CR21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.ajt.2023.06.008","volume":"23","author":"PP Pich\u00e9-Renaud","year":"2023","unstructured":"Pich\u00e9-Renaud PP, Yue Lee E, Ji C, et al. Safety and immunogenicity of the live-attenuated varicella vaccine in pediatric solid organ transplant recipients: A systematic review and meta-analysis. Am J Transpl. 2023;23:1757\u201370.","journal-title":"Am J Transpl"},{"key":"11275_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"11275_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, et al. GRADE guidelines. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401\u20136.","journal-title":"J Clin Epidemiol"},{"key":"11275_CR24","first-page":"1336","volume":"24","author":"Y Bai","year":"2011","unstructured":"Bai Y, Yang L, Guo L, et al. Safety and immunogenicity of Gelatin-free Freeze-dried live attenuated varicella vaccine. Chin J Biol. 2011;24:1336\u20138.","journal-title":"Chin J Biol"},{"key":"11275_CR25","first-page":"435","volume":"18","author":"G Bian","year":"2012","unstructured":"Bian G, Tang X, Shi H, et al. Study on safety and immunogenicity of imported and domestic varicella attenuated live vaccine (Freeze-dried) for children. Chin J Vaccin Immuniz. 2012;18:435\u2013768.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR26","first-page":"279","volume":"25","author":"Z Cai","year":"2012","unstructured":"Cai Z. Observation on reaction and immune effect of lyophilized live attenuated varicella vaccine. Med Inf. 2012;25:279\u201380.","journal-title":"Med Inf"},{"key":"11275_CR27","first-page":"435","volume":"15","author":"E Chen","year":"2009","unstructured":"Chen E, Jiang Z, Li Q, et al. Safety and immunogenicity of lyophilized live attenuated domestic varicella vaccine. Chin J Vaccin Immuniz. 2009;15:435\u20137.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR28","first-page":"194","volume":"29","author":"W Dai","year":"2017","unstructured":"Dai W, Pang H, Jiang Y, et al. Study on immune effects of the second dose of varicella vaccine. Sh J Prev Med. 2017;29:194\u20136.","journal-title":"Sh J Prev Med"},{"key":"11275_CR29","first-page":"296","volume":"48","author":"Z Gao","year":"2021","unstructured":"Gao Z, Wu Z, Ye X, et al. Evaluation of safety and immune efficacy of domestic lyophilized live attenuated varicella vaccine in childrenaged 1\u201312 years. Inter J Epidemiol Infect Dis. 2021;48:296\u2013301.","journal-title":"Inter J Epidemiol Infect Dis"},{"key":"11275_CR30","first-page":"311","volume":"28","author":"H Hu","year":"2015","unstructured":"Hu H. Evaluation of safety and immunogenicity of lyophilized live attenuated varicella vaccine. Med Inf. 2015;28:311.","journal-title":"Med Inf"},{"key":"11275_CR31","first-page":"610","volume":"29","author":"T Huang","year":"2016","unstructured":"Huang T, Si G, Li C, et al. Safety and immunogenicity of domestic and imported freeze-dried live attenuated varicella vaccine inoculated by a two-dose schedule in healthy population at ages of more than 12 years in China. Chin J Biol. 2016;29:610\u20135.","journal-title":"Chin J Biol"},{"key":"11275_CR32","first-page":"265","volume":"44","author":"Z Huang","year":"2018","unstructured":"Huang Z, Zhang J, Tang Y, et al. Immunogenicity and safety of 2 doses of live attenuated varicella vaccine in children under 3 years of age. South China J Prev Med. 2018;44:265\u20138.","journal-title":"South China J Prev Med"},{"key":"11275_CR33","doi-asserted-by":"publisher","first-page":"106489","DOI":"10.1016\/j.cct.2021.106489","volume":"107","author":"F Jiang","year":"2021","unstructured":"Jiang F, Zhang R, Guan Q, et al. Immunogenicity and safety of a live attenuated varicella vaccine in children 1\u201312 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial. Contemp Clin Trials. 2021;107:106489.","journal-title":"Contemp Clin Trials"},{"key":"11275_CR34","first-page":"12","volume":"21","author":"Z Jiang","year":"2009","unstructured":"Jiang Z, Chen E, Li Q, et al. Observation on side effect of the domestic lyophilized live attenuated varicella vaccine. Zh Prev Med. 2009;21:12\u20133.","journal-title":"Zh Prev Med"},{"key":"11275_CR35","first-page":"371","volume":"14","author":"Y Li","year":"2008","unstructured":"Li Y, Fang H, Nong Y, et al. Study on safety and immunogenicity of domestic freeze-dried live attenuated varicella vaccine. Appl Prev Med. 2008;14:371\u20133.","journal-title":"Appl Prev Med"},{"key":"11275_CR36","first-page":"1667","volume":"25","author":"Y Li","year":"2012","unstructured":"Li Y, Gao Z, Tao H, et al. Safety of freeze-dried live attenuated varicella vaccine. Chin J Biol. 2012;25:1667\u201370.","journal-title":"Chin J Biol"},{"key":"11275_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13020-019-0264-7","volume":"14","author":"Y Li","year":"2019","unstructured":"Li Y. Immunogenicity analysis of domestic varicella vaccine after booster immunization. China Prac Med. 2019;14:41\u20133.","journal-title":"China Prac Med"},{"key":"11275_CR38","first-page":"63","volume":"25","author":"X Liu","year":"2019","unstructured":"Liu X, Yang H, Li H, et al. Immunogenicity and safety of two doses of domestic varicella attenuated live vaccine among \u2265\u200913-year-old healthy population in a non-inferiority trial. Chin J Vaccin Immuniz. 2019;25:63\u20137.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR39","first-page":"9","volume":"7","author":"M Lu","year":"2010","unstructured":"Lu M, Liu Z, Li Y, et al. Evaluation on safety and immunogenicity of live attenuated varicella vaccine. Med Innov Chin. 2010;7:9\u201311.","journal-title":"Med Innov Chin"},{"key":"11275_CR40","first-page":"207","volume":"27","author":"X Lu","year":"2008","unstructured":"Lu X, Zhou W, Gu K, et al. Safety and immunogenicity of Changsheng technology freeze-dried live attenuated varicella vaccine. J Southeast Univ (Medical Sci Edition). 2008;27:207\u201311.","journal-title":"J Southeast Univ (Medical Sci Edition)"},{"key":"11275_CR41","first-page":"1298","volume":"29","author":"L Luo","year":"2016","unstructured":"Luo L, Liu X, Ma Y, et al. Safety and immunogenicity of freeze-dried live attenuated varicella vaccine. Chin J Biol. 2016;29:1298\u2013300.","journal-title":"Chin J Biol"},{"key":"11275_CR42","first-page":"1381","volume":"32","author":"S Luo","year":"2019","unstructured":"Luo S, Jiang D, Huang Y, et al. Immunogenicity and safety of two-dose and booster immunization schedules of domestic varicella vaccine. Chin J Biol. 2019;32:1381\u20135.","journal-title":"Chin J Biol"},{"key":"11275_CR43","first-page":"601","volume":"27","author":"R Ma","year":"2012","unstructured":"Ma R, Xu G, Pan X, et al. Observation on immunogenicity of domestic freeze-dried live attenuated varicella vaccine and immunity persistence one year after vaccination. Dis Surveill. 2012;27:601\u20133.","journal-title":"Dis Surveill"},{"key":"11275_CR44","first-page":"100707","volume":"34","author":"ZJ Mo","year":"2023","unstructured":"Mo ZJ, Huang SJ, Qiu LX, et al. Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial. Lancet Reg Health West Pac. 2023;34:100707.","journal-title":"Lancet Reg Health West Pac"},{"key":"11275_CR45","first-page":"428","volume":"34","author":"S Peng","year":"2018","unstructured":"Peng S, Liao Z, Wan X, et al. Safety of Chinese freeze - dried varicella attenuated live vaccine. J Med Pest Control. 2018;34:428\u201331.","journal-title":"J Med Pest Control"},{"key":"11275_CR46","first-page":"314","volume":"16","author":"Y Shen","year":"2003","unstructured":"Shen Y, Jiang X, Gu X, et al. Inoculation reaction and immune effect of domestic freeze-dried live attenuated varicella vaccine. Chin J Biol. 2003;16:314\u20135.","journal-title":"Chin J Biol"},{"key":"11275_CR47","first-page":"72","volume":"23","author":"Y Shen","year":"2007","unstructured":"Shen Y, Lu J, Chen H. Observation on the level of varicella immunity in children in kindergarten and the effect of domestic varicella vaccine. Chin J Public Health Manage. 2007;23:72\u20133.","journal-title":"Chin J Public Health Manage"},{"key":"11275_CR48","first-page":"445","volume":"15","author":"H Sun","year":"2003","unstructured":"Sun H, Yuan J, Liu X. Immunogenicity and cost-effectiveness analysis of domestic varicella vaccine. Sh J Prev Med. 2003;15:445\u20137.","journal-title":"Sh J Prev Med"},{"key":"11275_CR49","first-page":"702","volume":"22","author":"H Sun","year":"2009","unstructured":"Sun H, Fang H, Li R, et al. Adverse reaction and immunogenicity induced by Freeze-dried live attenuated varicella vaccine. Chin J Biol. 2009;22:702\u20134.","journal-title":"Chin J Biol"},{"key":"11275_CR50","first-page":"1516","volume":"25","author":"Y Tang","year":"2012","unstructured":"Tang Y, Su J, Xia Y, et al. Safety and immunogenicity of domestic gelatin-free freeze-dried live attenuated varicella vaccine. Chin J Biol. 2012;25:1516\u20139.","journal-title":"Chin J Biol"},{"key":"11275_CR51","first-page":"241","volume":"20","author":"Y Tang","year":"2014","unstructured":"Tang Y, Du F, Chen H, et al. Post-Marketing immunogenicity and safety of two different live attemuatal varicella vaccine. Chin J Vaccin Immuniz. 2014;20:241\u20134.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR52","first-page":"813","volume":"22","author":"F Wang","year":"2006","unstructured":"Wang F, Chen Z, Chen X. Observation on efficacy of live attenuated varicella vaccine in Weifang City. Med Anim Control. 2006;22:813\u20134.","journal-title":"Med Anim Control"},{"key":"11275_CR53","first-page":"30","volume":"29","author":"L Wang","year":"2003","unstructured":"Wang L, Liu Y, Li L, et al. Observation on immune effect of domestic freeze-dried live attenuated varicella vaccine. South China J Prev Med. 2003;29:30\u20131.","journal-title":"South China J Prev Med"},{"key":"11275_CR54","first-page":"711","volume":"29","author":"Q Wang","year":"2017","unstructured":"Wang Q, Li Y, Wang L. Safety and immunogenicity of lyophilized live attenuated varicella vaccine in children aged 1\u20136 years. Prev Med. 2017;29:711\u20133.","journal-title":"Prev Med"},{"key":"11275_CR55","first-page":"531","volume":"17","author":"Z Wang","year":"2011","unstructured":"Wang Z, Xiao Q, Li F, et al. Safety and immunological effect of domestic varicella attenuated live vaccine (Freeze-dried). Chin J Vaccin Immuniz. 2011;17:531\u20134.","journal-title":"Chin J Vaccin Immuniz"},{"key":"11275_CR56","first-page":"59","volume":"29","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Fei J, Zhong P, et al. Study on safety and immunogenicity of domestic freeze-dried live attenuated varicella vaccine with 2 doses. Sh Prev Med. 2017;29:59\u201361.","journal-title":"Sh Prev Med"},{"key":"11275_CR57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","volume":"21","author":"HR Shinefield","year":"2002","unstructured":"Shinefield HR, Black SB, Staehle BO, et al. Vaccination with measles, mumps and Rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children. Pediatr Infect Dis J. 2002;21:555\u201361.","journal-title":"Pediatr Infect Dis J"},{"key":"11275_CR58","unstructured":"National Advisory Committee on Immunization (NACI). Varicella (chicken pox) vaccine: Canadian Immunization Guide [internet]. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-24-varicella-chickenpox-vaccine.html"},{"key":"11275_CR59","first-page":"176","volume":"6","author":"X Shi","year":"2019","unstructured":"Shi X. Comparative study on immune effect of domestic and imported varicella vaccine. Electron J Clin Med Literature. 2019;6:176.","journal-title":"Electron J Clin Med Literature"},{"key":"11275_CR60","doi-asserted-by":"publisher","first-page":"2341456","DOI":"10.1080\/21645515.2024.2341456","volume":"20","author":"V Carta","year":"2024","unstructured":"Carta V, Mangeri L, Tiecco G, et al. Immunogenicity and safety of live attenuated and recombinant\/inactivated varicella Zoster vaccines in people living with HIV: A systematic review. Hum Vaccin Immunother. 2024;20:2341456.","journal-title":"Hum Vaccin Immunother"},{"key":"11275_CR61","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14760584.2018.1433999","volume":"17","author":"M Yin","year":"2018","unstructured":"Yin M, Xu X, Liang Y, et al. Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: a meta-analysis. Expert Rev Vaccines. 2018;17:351\u201362.","journal-title":"Expert Rev Vaccines"},{"key":"11275_CR62","doi-asserted-by":"crossref","unstructured":"Su JR, Leroy Z, Lewis PW et al. Safety of Second-Dose Single-Antigen varicella vaccine. Pediatrics. 2017;139:e20162536.","DOI":"10.1542\/peds.2016-2536"},{"key":"11275_CR63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/INF.0000000000001241","volume":"35","author":"BJ Kuter","year":"2016","unstructured":"Kuter BJ, Brown M, Wiedmann RT, et al. Safety and immunogenicity of M-M-RII (Combination Measles-Mumps-Rubella Vaccine) in clinical trials of healthy children conducted between 1988 and 2009. Pediatr Infect Dis J. 2016;35:1011\u201320.","journal-title":"Pediatr Infect Dis J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11275-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11275-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11275-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T10:03:01Z","timestamp":1751709781000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11275-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11275"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11275-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"897"}}